Similar to what Colin said, we've researched these amendments, and the opinion we've received from the department is that this would change the scope of the bill. Ms. Fry is absolutely correct; it's very clear in the bill that this is about dense breast tissue.
I'm sure this is not your intention, but unfortunately all of these amendments, including this one, would make it non-receivable in the House. I know it's not your intention to kill the bill, but these amendments would be that poison pill.
That's why I can't support this. I don't want to lose the work that we're focusing on for dense breast tissue by saying breast cancer screening “including” breast density. That makes the patients with breast density a sidebar rather than the focus, and that changes the scope. That's the opinion so far that we've received.